Michor Franziska

Michor Franziska is listed in filings as Director at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 23, 2025, including 10 public disclosures. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX). The current snapshot covers public activity from Nov 22, 2024 to Jun 23, 2025. Reported amounts are shown as $112.2K to $148.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.